Brain/Beh Chapter 4
Introduction to Drugs and Their Functions
Discussion on the overview of drugs, focusing on their functional classes rather than specific drugs.
Agonists:
Definition: Drugs that function similarly to endogenous neurotransmitters.
Mechanism: When binding to its target receptor, an agonist should have a similar effect as the neurotransmitter, opening ion channels for ion exchange, e.g., Na or Cl.
Example: Dopamine agonists activate channels similarly to dopamine itself.
Antagonists:
Definition: Drugs meant to inhibit or block the action of endogenous molecules.
Mechanism: They do not activate receptors but prevent the endogenous molecule from binding, essentially acting as receptor blockers (also called channel blockers).
Types of Agonists and Antagonists
Distinction between Direct and Indirect actions:
Direct Agonist/Antagonist: Binds to the same site as the endogenous molecule.
Competitive: They must compete for the same binding site, and the one that binds first determines the outcome.
Indirect Agonist/Antagonist: Binds to an alternative or modulatory binding site, does not directly compete for the same site.
Noncompetitive: Prevents action even if the endogenous molecule is present.
Receptor Functionality and Drug Interaction
Receptors generally consist of multiple protein subunits, creating various binding sites.
Binding site specificity helps understanding functional classifications of drugs.
Agonists and antagonists vary in effectiveness based on how they interact with receptor binding sites.
Routes of Drug Administration and Onset of Action
Ingestion:
Slow onset as the drug must pass through the digestive system to the bloodstream.
Acidic environments may require higher doses to account for breakdown before absorption.
Injection:
Intravenous (IV): Fastest onset as drug is directly injected into the bloodstream.
Other methods (intramuscular, subcutaneous) offer moderately fast effects.
Inhalation Methods:
Smoking or snorting enables rapid absorption due to dense blood vessel distribution in lungs/nose.
Central Injection:
Directly into the brain (e.g., intrathecal), leading to immediate action at the target site.
Pharmacokinetic Profile of Drugs
Pharmacokinetics encompasses absorption, distribution, metabolism, and excretion following drug administration, which ultimately affects its action onset and duration in the body.
Factors influencing pharmacokinetics include the route of administration and the chemical properties of the drug.
Illustrated using a graph showing plasma cocaine levels over time based on route of administration:
IV administration leads to peak concentration instantly, while oral ingestion leads to significant lag time.
Drug Properties: Affinity and Efficacy
Affinity:
Refers to how tightly a drug binds to its target receptor.
High affinity means long attachment to its receptor, while low affinity denotes shorter binding duration.
Efficacy:
Represents the intrinsic response a drug produces upon binding to a receptor.
Agonists can have varying efficacy; antagonists are characterized as having zero efficacy since they do not activate receptors.
Dose-Response Curve:
A curve used to determine the relationship between drug dosage and its effects, including a plateau where maximum effect is achieved, thus preventing further increased effectiveness with higher doses.
Understanding Drug Tolerance and Margins of Safety
Tolerance:
Reduced responsiveness to a drug resulting from repeated administration, necessitating higher doses to achieve the same effect.
Two forms of tolerance addressed: Physiological (e.g., metabolic changes leading to rapid breakdown of the drug) and Behavioral (improvement in task performance despite intoxication).
Margin of Safety:
The difference between effective doses and those that produce harmful side effects, ensuring safe and effective drug administration.